KBL MERGER CORP. IV Human Resources Contracts & Agreements
44 Contracts & Agreements
- Bonus & Incentive Agreements (7 contracts)
- Compensation Agreements (1)
- Consulting Agreements (10)
- Employment Agreements (21)
- Separation Agreements (5)
- Separation and Release Agreement dated September 5, 2024 and First Amendment to Separation and Release Agreement dated September 5, 2024, by and between Cannbiorex Pharma Ltd.,... (Filed With SEC on September 9, 2024)
- Executive Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. , Blair Jordan and Blair Jordan Strategy and Finance Consulting Inc (Filed With SEC on May 9, 2024)
- Fourth Amendment to Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Lawrence Steinman (Filed With SEC on May 9, 2024)
- Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Jonathan Rothbard (Filed With SEC on May 9, 2024)
- Separation and Release Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Jonathan Rothbard (Filed With SEC on May 9, 2024)
- Separation and Release Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. James N. Woody (Filed With SEC on May 9, 2024)
- Second Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on February 16, 2024)
- Second Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on February 16, 2024)
- Second Amendment to Consulting Agreement dated January 10, 2024 and effective as of January 1, 2024, between Cannbiorex Pharma Ltd. and Sir Marc Feldmann (Filed With SEC on January 17, 2024)
- Third Amendment to Consulting Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and Lawrence Steinman, M.D (Filed With SEC on January 17, 2024)
- Fourth Amendment to Employment Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on January 17, 2024)
- Fourth Amendment to Employment Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on January 17, 2024)
- 180 Life Sciences Corp. Policy for the Recovery of Erroneously Awarded Incentive-Based Compensation (Filed With SEC on November 9, 2023)
- Form of Stock Option Agreement (First Amended and Restated 2022 Omnibus Incentive Plan) (Filed With SEC on September 7, 2023)
- First Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on July 10, 2023)
- First Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on July 10, 2023)
- Amended and Corrected Third Amendment to Employment Agreement dated May 9, 2023, between 180 Life Sciences Corp. and Ozan Pamir (Filed With SEC on May 15, 2023)
- Third Amendment to Employment Agreement dated April 27, 2023 and effective as of January 1, 2023, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on April 28, 2023)
- Third Amendment to Employment Agreement dated April 27, 2023 and effective as of January 1, 2023, between 180 Life Sciences Corp. and Ozan Pamir (Filed With SEC on April 28, 2023)
- Third Amendment to Employment Agreement dated April 27, 2023 and effective as of January 1, 2023, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on April 28, 2023)
- First Amendment to Separation and Release Agreement, dated March 29, 2023, by and between 180 Life Sciences Corp. and Quan Vu (Filed With SEC on March 31, 2023)
- Separation and Release Agreement, dated January 18, 2023, by and between 180 Life Sciences Corp. and Quan Vu (Filed With SEC on January 20, 2023)
- Third Amendment to Consulting Agreement dated December 28, 2022, between 180 Life Sciences Corp., Cannbiorex Pharma Ltd. and Prof. Jagdeep Nanchahal (Filed With SEC on December 29, 2022)
- 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (Filed With SEC on June 14, 2022)
- Second Amendment to Consulting Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Lawrence Steinman, M.D (Filed With SEC on May 27, 2022)
- Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on May 27, 2022)
- Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Quan Anh Vu (Filed With SEC on May 27, 2022)
- Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on May 27, 2022)
- Second Amendment to Consulting Agreement dated April 27, 2022, between Cannbiorex Pharma Ltd. and Prof. Jagdeep Nanchahal (Filed With SEC on April 28, 2022)
- First Amendment to Consulting Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Lawrence Steinman, M.D (Filed With SEC on April 28, 2022)
- First Amendment to Employment Agreement dated April 27, 2022, between Cannbiorex Pharma Ltd. and Sir Marc Feldmann, Ph.D (Filed With SEC on April 28, 2022)
- First Amendment to Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D (Filed With SEC on April 28, 2022)
- First Amendment to Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Quan Anh Vu (Filed With SEC on April 28, 2022)
- First Amendment to Amended and Restated Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D (Filed With SEC on April 28, 2022)
- Consulting Agreement dated November 17, 2021, by and between 180 Life Science Corp. and Lawrence Steinman, M.D (Filed With SEC on November 18, 2021)
- Employment Agreement dated October 29, 2021, by and between 180 Life Sciences Corp. and Quan Anh Vu (Filed With SEC on November 2, 2021)
- Second Amendment to Employment Agreement dated May 27, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp., Katexco Pharmaceuticals Corp. and Ozan Pamir (Filed With SEC on May 27, 2021)
- Employment Agreement dated February 24, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp. and Ozan Pamir and Amendment and Correction Thereto dated... (Filed With SEC on March 3, 2021)
- Amended and Restated Employment Agreement dated February 25, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp. and James N. Woody (Filed With SEC on March 3, 2021)
- First Amendment to Employment Agreement by and between 180 Life Corp. (f/k/a 180 Life Sciences Corp.) and James N. Woody, M.D., Ph.D (Filed With SEC on November 12, 2020)
